Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Acta Cytol ; 66(6): 486-495, 2022.
Article in English | MEDLINE | ID: mdl-36067732

ABSTRACT

INTRODUCTION: Demonstration of diagnostic contribution of Papanicolaou Society of Cytopathology-standardized nomenclature for pancreaticobiliary cytology (PSC-PC) in endoscopic ultrasonography (EUS) fine-needle biopsy (FNA) biopsies is important for widespread use and further development. METHODS: 179 EUS-FNA biopsies (89: solid, 90: cystic) and PSC-PC categories were compared with surgical definite histopathology and definite clinical diagnosis. Overall risk of malignancy (oROM) was calculated for each PSC-PC category. Diagnostic accuracy was evaluated. RESULTS: The cytopathology of lesions was nondiagnostic in 27%. Ductal dilatation, lymphadenopathy, and solid characteristic (independently) were associated with diagnostic result, while lesion size was not. PSC-PC categories had 89% diagnostic consistency with surgical definite histopathology. Category mismatch was detected in 3 patients (11%), of which 2 had adenocarcinoma. oROM was 14.3% for nondiagnostic group, 46% for cat. III (atypia), and 12% for cat. IVB (neoplastic - other). In terms of malignancy, the PSC-PC system had 100% specificity; PPV, 92% sensitivity, and 81% NPV; and the diagnostic accuracy was 94%. CONCLUSION: Using PSC-PC in EUS-FNA biopsies, pancreatic malignancy can be diagnosed with high diagnostic accuracy. In mucinous cystic lesions, some malignancies may be missed. To predict the malignancy risk of cat. IVB, assessment of dysplasia seems important. Although PSC-PC is not the only parameter in terms of diagnosing malignancy, its contribution to the clinical decision is quite high.


Subject(s)
Pancreas , Pancreatic Neoplasms , Humans , Pancreas/pathology , Pancreatic Neoplasms/pathology , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Endosonography , Sensitivity and Specificity
2.
Aging Clin Exp Res ; 29(6): 1165-1171, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28120284

ABSTRACT

BACKGROUND: Data on the prevalence of fecal incontinence in elderly patients admitted to outpatient clinics in Turkey are scarce. AIMS: The aim of this study was to assess the prevalence of fecal incontinence and the associated risk factors in the elderly outpatients. METHODS: Patients 60 years and older admitted to a geriatrics outpatient clinic between October 2013 and March 2014 were included. Demographic characteristics, anthropometric measurements, marital status, educational status, parity (for females), fecal incontinence (FI), urinary incontinence (UI), constipation, comorbid conditions, and medications were recorded. FI assessment was based on the Fecal Incontinence Severity Index (FISI). RESULTS: A total of 364 patients (64.8% female, n = 236) with a mean age of 73.2 ± 8.1 years were enrolled in the study. The prevalence of FI was 9.9% (10.2% female, 9.4% male). UI was 42.6%. Co-occurrence of FI and UI was 7.4%. According to the FISI, the most frequent type of defecation was liquid stool (61.1%). While the predictive factors for FI were polypharmacy (standardized coefficient, [r] = 0.203, 95% confidence interval [CI] = 0.009-0.040, p = 0.002), UI (r = 0.134, 95% CI = 0.006-0.156, p = 0.035), and being married (r = 0.200, 95% CI = -0.088 to -0.020, p = 0.002) in females, those were UI (r = 0.306, 95% CI = 0.093-0.309, p < 0.001) and polypharmacy (r = 0.251, 95% CI = 0.009-0.043, p = 0.003) in males. CONCLUSIONS: In both genders, urinary incontinence and polypharmacy seem to be the most important risk factors for fecal incontinence. Fecal incontinence should be questioned in detail and evaluated using FISI in elderly outpatients.


Subject(s)
Fecal Incontinence/epidemiology , Polypharmacy , Aged , Aged, 80 and over , Comorbidity , Constipation/epidemiology , Cross-Sectional Studies , Fecal Incontinence/etiology , Female , Humans , Male , Middle Aged , Outpatients/statistics & numerical data , Prevalence , Risk Factors , Severity of Illness Index , Sex Factors , Turkey/epidemiology , Urinary Incontinence/epidemiology
3.
Turk J Gastroenterol ; 27(4): 361-6, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27458852

ABSTRACT

BACKGROUND/AIMS: Oxidative stress and insulin resistance (IR) are major contributors in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). The purpose of this study was to find the relation between oxidative stress parameters and histopathological findings in NAFLD patients with and without insulin resistance (IR). MATERIALS AND METHODS: Thirty-two patients with no alcohol intake and biopsy-proven diagnosis of NAFLD were studied (M/F: 17/15; mean age 46.5±11.4 years). Twenty-one NAFLD patients with IR were compared with 11 patients without IR. The fasting insulin level was measured, and the insulin resistance index was calculated using the homeostasis model assessment (HOMA) method. Malondialdehyde (MDA) and superoxide dismutase (SOD) activities were measured in tissue and serum specimens. Glutathione (GH) was measured in tissue homogenates. Nitric oxide (NO), vitamin E and C levels were measured in serum. RESULTS: Patients with IR had significantly higher tissue MDA levels (p=0.001) and significantly decreased tissue SOD and GH levels (p=0.001 and 0.002, respectively) than those without IR. The steatosis grade, necroinflammatory grade and stage were significantly higher in patients with IR (p=0.035, 0.003 and 0.001, respectively). HOMA IR significantly correlated with the necroinflammatory grade, stage, tissue MDA, SOD and GH (p=0.013, 0.001, 0.008, 0.001 and 0.001, respectively). Serum MDA (ß=1.88, p=0.002), serum SOD (ß=0.57, p=0.006), tissue MDA (ß=0.22, p=0.006), tissue SOD (ß=1.48, p=0.071) and stage (ß=2.81, p=0.003) were independently associated with increased HOMA IR. Increased MDA [OR: 1.51; 95% CI: (1.03-2.22); p=0.034] was a risk factor for non-alcoholic steatohepatitis (NASH), and increased SOD activity had a preventive effect against NASH [OR: 0.008; 95% CI: (0.001-0.98); p=0.04]. CONCLUSION: This study shows that insulin resistance in NAFLD correlates with enhanced oxidative stress. Histopathological disease severity significantly correlated with oxidative stress parameters. These data show that NAFLD patients with IR may have increased risk for disease progression.


Subject(s)
Insulin Resistance/physiology , Non-alcoholic Fatty Liver Disease/physiopathology , Oxidative Stress/physiology , Severity of Illness Index , Adult , Ascorbic Acid/blood , Female , Glutathione/analysis , Humans , Insulin/blood , Liver/physiopathology , Male , Malondialdehyde/analysis , Middle Aged , Nitric Oxide/blood , Non-alcoholic Fatty Liver Disease/blood , Superoxide Dismutase/analysis , Vitamin E/blood
4.
Clin Endosc ; 49(5): 479-482, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27353368

ABSTRACT

Internal radioembolization with yttrium-90 is a promising treatment method, predominantly for liver tumors. However, the shifting of yttrium-90-loaded spherules into the arteries and veins that supply the duodenum and stomach, leading to ulceration, hemorrhage, perforation, and outlet obstruction of these organs, is one of the major undesirable consequences of this technique. We report a case of gastric outlet obstruction (GOO) due to antropyloric stenosis with ulceration, edema, and inflammation following transarterial yttrium-90 treatment for a metastatic neuroendocrine tumor in a 58-year-old man. Stenting was used for palliation in this case. GOO improved after stenting and recovery of oral intake was permanent after stent removal.

5.
Case Rep Med ; 2015: 971607, 2015.
Article in English | MEDLINE | ID: mdl-26819619

ABSTRACT

Eosinophilic gastroenteritis is a rare disorder of unknown cause characterized by focal or diffuse eosinophilic infiltration of gastrointestinal tract, especially the stomach and duodenum. Its clinical presentation depends on which segment of gastrointestinal tract is affected and on the depth of eosinophilic infiltration in the affected segment. We present a case of a 35-year-old male with abdominal distention for six months. Laboratory testing revealed elevated eosinophil count and serum immunoglobulin E (IgE) levels. In abdominal tomography, ascites was observed, and eosinophilic infiltration was detected in duodenum biopsy samples, collected during endoscopic examination of upper gastrointestinal system. Clinical and pathologic findings of the patient responded to steroid dramatically. Even though their comorbidity is rare, eosinophilic gastroenteritis should be considered in differential diagnosis of patients with unspecified ascites.

6.
Diagn Ther Endosc ; 2014: 262638, 2014.
Article in English | MEDLINE | ID: mdl-25276089

ABSTRACT

Objectives. We have investigated the changes in the incidence of various diagnoses that have been made in the endoscopy unit throughout the last 40 years. Methods. In this study, changes in the incidence of endoscopic diagnosis in upper gastrointestinal system between 1970 and 2010 were evaluated. Their diagnosis, age, and gender data were entered into the Excel software. Results. Of the 52816 cases who underwent esophagogastroduodenoscopy in the 40-year time period, the mean age was 48.17 ± 16.27 (mean ± SD). Although overall more than half of the patients were male (54.3%), in 1995 and after a marked increase was seen in the proportion of female gender (51-55%). The presence of hiatal hernia, reflux esophagitis, and the number of Barrett's esophaguses significantly increased. Erosive gastritis showed gradual increase, while the number of gastric ulcers decreased significantly. The presence of gastric and esophageal cancer significantly decreased. The number of duodenal ulcers significantly decreased. Conclusion. We detected that the incidences of esophagitis, Barrett's esophagus, and erosive gastritis significantly increased while the incidences of gastric/duodenal ulcer and gastric/esophageal cancer decreased throughout the last 40 years.

7.
Dig Endosc ; 25(5): 502-7, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23369002

ABSTRACT

BACKGROUND: Our aim was to study the efficacy and safety of different types of intragastric balloon in morbidly obese patients. PATIENTS AND METHODS: From 2005 to 2011, intragastric balloons were inserted endoscopically into 32 patients. Intragastric balloons were used in morbidly obese (body mass index [BMI] ≥ 35 kg/m(2) ) individuals who were non-responsive to 6-month medical therapy and diet. Balloons were endoscopically removed after 6 months. RESULTS: Thirty-six balloons were inserted in a total of 32 patients. Mean age of the patients was 37.28 ± 12.08 (17-64) years and mean height was 169.81 ± 8.17 (150-185) cm. Initial mean weight was 128.87 ± 23.31 kg and BMI was 45.26 ± 8.48 kg/m(2) . At month 6, mean bodyweight was 116.93 ± 23.18 and BMI was 40.96 ± 7.96 kg/m(2) (P < 0.001, P < 0.001, respectively). At the end of 6 months, while the excessweight loss (EWL) median was 13.0 kg, [interquartile range IQR: 5.0-16.0] and percent EWL median was 21.92, [IQR: 12.72-28.49] in the Heliosphere BAG patients, the EWL median was 19.0 kg, [IQR: 14.47-26.72] and the percent EWL median was 38.26, [IQR: 19.73-47.79] in the BioEnterics Intragastric Balloon patients (P = 0.006, P = 0.010, respectively for EWL median and percent EWL median). One patient died (3.1%) of cardiac arrest due to aspiration at day 13 after BIB placement. CONCLUSION: Although not without risk, intragastric balloon placement is an effective method for weight loss. BioEnterics Intragastric Balloon is more effective in helping weight loss than the Heliosphere BAG balloon.


Subject(s)
Gastric Balloon/statistics & numerical data , Gastroscopy/methods , Obesity, Morbid/therapy , Weight Loss , Adolescent , Adult , Air , Analysis of Variance , Body Mass Index , Chi-Square Distribution , Cohort Studies , Equipment Design , Equipment Safety , Female , Follow-Up Studies , Humans , Male , Middle Aged , Obesity, Morbid/diagnosis , Patient Safety , Retrospective Studies , Risk Assessment , Treatment Outcome , Water , Young Adult
8.
Clin Endosc ; 46(1): 59-64, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23423384

ABSTRACT

BACKGROUND/AIMS: To asses the usefulness of flexible metallic stents in the palliation of malignant obstruction of gastric outlet and duodenum. METHODS: Retrospective review was performed between January 2006 and December 2011 in 30 patients. Thirty consecutive patients with obstruction of the gastric outlet underwent palliative treatment with self-expandable flexible metallic stents. Complications and clinical outcomes were assessed. RESULTS: Twenty-four patients had advanced gastric carcinoma at the antrum and/or pylorus, four patients had obstruction at the pylorus due to pancreas tumours and one patient had duodedum and one patient had gall bladder tumour. Symptoms improved in 82.7% of the patients after the procedure. The improvement in ability to eat using the score system was statistically significant (p<0.001). Tumor ingrowth and/or overgrowth were seen in four patients (13.3%), and a second stent was inserted in these patients. The mean stent patency was 100 days (range, 5 to 410). The mean survival was 120.76±38.96 days. CONCLUSIONS: Endoscopic placement of self-expendable metallic stents under fluoroscopy is a safe and effective treatment for the palliation of patients with inoperable malignant gastric outlet obstruction caused by stomach or pancreas cancer.

9.
Turk J Gastroenterol ; 23(5): 585-9, 2012.
Article in English | MEDLINE | ID: mdl-23161306

ABSTRACT

A case of eosinophilic gastroenteritis is reported in a 17-year-old woman. The disease has the signs of delayed gastric emptying, vomiting, weight loss, and substantial thickening of the gastric antrum. Histopathology established the diagnosis of eosinophilic gastroenteritis of panmural type. Improvement in the patient's symptoms and laboratory parameters was observed with steroid treatment. The clinicopathological features of this disease are summarized in the discussion.


Subject(s)
Duodenitis/diagnosis , Eosinophilia/diagnosis , Gastroenteritis/diagnosis , Lymphoma, Non-Hodgkin/diagnosis , Stomach Neoplasms/diagnosis , Adolescent , Biopsy , Diagnosis, Differential , Duodenitis/complications , Endoscopy, Gastrointestinal , Eosinophilia/etiology , Female , Gastroenteritis/etiology , Humans , Pancreatitis , Positron-Emission Tomography , Tomography, X-Ray Computed
11.
Hepatogastroenterology ; 58(112): 1963-7, 2011.
Article in English | MEDLINE | ID: mdl-22024068

ABSTRACT

BACKGROUND/AIMS: The aim of this retrospective survey is to determine the frequency of collagenous colitis among patients who presented with chronic diarrhea to our gastroenterology outpatient clinic and to evaluate the demographic, clinical and laboratory findings of these patients and the treatment modalities. METHODOLOGY: We reviewed the charts of the patients who had presented with chronic diarrhea to our outpatient clinic during four years. We identified the patients who were diagnosed to have collagenous colitis on histopathological examination. RESULTS: Among the 93 patients who presented with chronic diarrhea, 7 (7.5%) were diagnosed as collagenous colitis. Six of these patients were female, the mean age was 64 ± 11.5 years. Celiac disease was diagnosed in 2 of these patients. Laboratory examination showed anemia in 2 patients, hypoalbuminemia in 4 patients and high C-reactive protein levels in 3 patients. Five patients were treated with mesalazine, 1 patient with salazopyrine and 1 with methylprednisolone. Remission was obtained in all of these patients except for one; in this case budesonide was started instead of mesalazine. CONCLUSIONS: Collagenous colitis was detected in 7.5% of the patients who presented with chronic diarrhea to our gastroenterology outpatient clinic. They were usually middle aged female patients. Mesalazine was effective in most of these patients.


Subject(s)
Colitis, Collagenous/epidemiology , Diarrhea/etiology , Aged , Aged, 80 and over , Chronic Disease , Colitis, Collagenous/drug therapy , Colitis, Collagenous/pathology , Female , Humans , Male , Mesalamine/therapeutic use , Middle Aged , Retrospective Studies
12.
World J Gastroenterol ; 16(45): 5739-45, 2010 Dec 07.
Article in English | MEDLINE | ID: mdl-21128325

ABSTRACT

AIM: To evaluate the efficacy of self expandable metallic stents (SEMS) in patients with malignant esophageal obstruction and fistulas. METHODS: SEMS were implanted in the presence of fluoroscopic guidance in patients suffering from advanced and non-resectable esophageal, cardiac and invasive lung cancer between 2002 and 2009. All procedures were performed under conscious sedation. All patients had esophagus obstruction and/or fistula. In all patients who required reintervention, recurrence of dysphagia, hemorrhage, and fistula formation were indications for further endoscopy. Patients' files were scanned retrospectively and the obtained data were analyzed using SPSS 13.0 for Windows. The χ(2) test was used for categorical data and was analysis of variance for non-categorical data. Patients' long-term survival was assessed using the Kaplan-Meier method. RESULTS: Stents were successfully implanted in 90 patients using fluoroscopic guidance. Reasons for stent implantation in these patients were esophageal stricture (77/90, 85.5%), external pressure (8/90, 8.8%) and tracheo-esophageal fistula (5/90, 5.5%). Dysphagia scores (mean ± SD) were 3.37 ± 0.52 before and 0.90 ± 0.43 after stent implantation (P = 0.002). Intermittent, non-massive hemorrhage due to the erosion caused by the distal end of the stent in the stomach occurred in only one patient who received implementation at cardio-esophageal junction. Mean survival following stenting was 134.14 d (95% confidence interval: 94.06-174.21). CONCLUSION: SEMS placement is safe and effective in the palliation of dysphagia in selected patients with malignant esophageal strictures.


Subject(s)
Esophageal Neoplasms/complications , Esophageal Stenosis/therapy , Esophagoscopy/instrumentation , Metals , Stents , Thoracic Neoplasms/complications , Tracheoesophageal Fistula/therapy , Adult , Aged , Aged, 80 and over , Catheterization , Chi-Square Distribution , Conscious Sedation , Deglutition Disorders/etiology , Deglutition Disorders/therapy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Esophageal Stenosis/etiology , Esophageal Stenosis/mortality , Esophagoscopy/adverse effects , Female , Foreign-Body Migration/etiology , Hemorrhage/etiology , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Invasiveness , Palliative Care , Prosthesis Design , Retrospective Studies , Survival Rate , Thoracic Neoplasms/mortality , Thoracic Neoplasms/pathology , Time Factors , Tracheoesophageal Fistula/etiology , Tracheoesophageal Fistula/mortality , Treatment Outcome , Turkey
14.
Clinics (Sao Paulo) ; 64(12): 1195-200, 2009.
Article in English | MEDLINE | ID: mdl-20037707

ABSTRACT

AIM: In our study, we investigated the levels of glutamic acid decarboxylase antibody (anti-GAD), islet cell antibody (ICA), thyroperoxidase antibody (anti-TPO), thyroglobulin antibody (anti-TG), antinuclear antibodies (FANA), antibodies to double-stranded DNA (anti-ds DNA), antibody to Sjögren syndrome A antigen (anti-SSA), antibody to Sjögren syndrome B antigen (anti-SSB), Smith antibody (anti-Sm), smooth muscle antibodies (ASMA), and antimitochondrial antibody liver-kidney microsome (AMA-LKM) in patients with celiac disease as compared to healthy controls and autoimmune hypothyroid patients. MATERIALS AND METHODS: A total of 31 patients with celiac disease, 34 patients with autoimmune hypothyroidism and 29 healthy subjects were included in this study. Anti-SSA, anti-SSB, anti-Sm, anti-ds DNA, anti-GAD, anti-TPO and anti-TG were studied by Enzyme-Linked Immunosorbent Assay (ELISA), and AMA-LKM, ASMA, ANA and ICA were studied by immunofluorescence. Clinical data and the results of free thyroxine-thyroid stimulating hormone (FT4-TSH) were collected from the patients' files by retrospective analysis. SPSS ver 13.0 was used for data analysis, and the chi(2) method was used for comparisons within groups. RESULTS: The frequency of anti-SSA, anti-SSB, anti-GAD, anti-Sm, anti-ds DNA, AMA-LKM, ASMA, ANA and ICA were not significantly different between the groups. Levels of anti-TPO and anti-TG antibodies were found to be significantly higher (<0.001) in autoimmune hypothyroid patients when compared with other groups. CONCLUSION: In previous studies, an increased frequency of autoimmune diseases of other systems has been reported in patients with celiac disease. We found that the frequency of autoimmune antibodies specific for other autoimmune diseases was not higher in celiac disease.


Subject(s)
Autoantibodies/blood , Celiac Disease/immunology , Adult , Autoantibodies/classification , Autoimmune Diseases/immunology , Case-Control Studies , Female , Humans , Hypothyroidism/immunology , Male , Retrospective Studies
15.
Dig Dis Sci ; 54(5): 980-7, 2009 May.
Article in English | MEDLINE | ID: mdl-19267195

ABSTRACT

AIM/BACKGROUND: Lye (NaOH) ingestion in humans often results in alkaline damage to the esophagus, but knowledge about this process is limited. Here, we explore the effects of lye on esophageal epithelial structure and function using rabbit esophageal epithelium as a model of lye ingestion. METHODS: Rabbit esophageal epithelium was mounted in Ussing chambers so that the electrical potential difference (PD), short-circuit current (I (sc)), and transepithelial resistance (R (T)) could be monitored before, during, and after mucosal exposure to lye (NaOH) at pHs ranging from 7.4 to 12.1. Histopathology and dextran fluxes were also performed and correlated with the electrical data. RESULTS: Mucosal exposure to lye at pHs <11.5 had no damaging effects on the esophagus. However, at pHs >or=11.5, damage was both time- and pH-dependent, as noted by increases in PD and I (sc), and declines in R (T). Further, the electrical changes were paralleled morphologically by epithelial liquefaction necrosis and increases in dextran flux. Also, by pretreating tissues with ouabain, the early lye-induced rise in PD and I (sc) was shown to result from a combination of increased active (sodium) transport and passive (sodium) diffusion which indicates that, even early on, the damaging effects of lye include changes in both apical cell membranes and tight junctions of this epithelium. CONCLUSION: Lye (NaOH) injury to the esophageal epithelium is both pH- and time-dependent, but requires a minimum pH of 11.5. At pHs >or=11.5, lye produces liquefaction necrosis, an injury that involves both cellular and junctional barriers, and which markedly increases epithelial permeability to ions and uncharged molecules. Based on these results, non-industrial cleaning products in the home are likely to be safer if they have a concentration of lye below pH 11.5.


Subject(s)
Caustics/toxicity , Epithelial Cells/drug effects , Esophageal Diseases/chemically induced , Esophagus/drug effects , Sodium Hydroxide/toxicity , Animals , Cell Membrane/drug effects , Cell Membrane/pathology , Diffusion , Electric Impedance , Enzyme Inhibitors/pharmacology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Esophageal Diseases/pathology , Esophagus/injuries , Esophagus/metabolism , In Vitro Techniques , Male , Membrane Potentials , Mucous Membrane/drug effects , Mucous Membrane/pathology , Necrosis , Ouabain/pharmacology , Permeability , Rabbits , Sodium/metabolism , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/metabolism , Tight Junctions/drug effects , Tight Junctions/pathology , Time Factors
16.
Clinics ; 64(12): 1195-1200, 2009. tab
Article in English | LILACS | ID: lil-536222

ABSTRACT

AIM: In our study, we investigated the levels of glutamic acid decarboxylase antibody (anti-GAD), islet cell antibody (ICA), thyroperoxidase antibody (anti-TPO), thyroglobulin antibody (anti-TG), antinuclear antibodies (FANA), antibodies to double-stranded DNA (anti-ds DNA), antibody to Sjõgren syndrome A antigen (anti-SSA), antibody to Sjõgren syndrome B antigen (anti-SSB), Smith antibody (anti-Sm), smooth muscle antibodies (ASMA), and antimitochondrial antibody liver-kidney microsome (AMA-LKM) in patients with celiac disease as compared to healthy controls and autoimmune hypothyroid patients. MATERIALS AND METHODS: A total of 31 patients with celiac disease, 34 patients with autoimmune hypothyroidism and 29 healthy subjects were included in this study. Anti-SSA, anti-SSB, anti-Sm, anti-ds DNA, anti-GAD, anti-TPO and anti-TG were studied by Enzyme-Linked Immunosorbent Assay (ELISA), and AMA-LKM, ASMA, ANA and ICA were studied by immunofluorescence. Clinical data and the results of free thyroxine-thyroid stimulating hormone (FT4-TSH) were collected from the patients' files by retrospective analysis. SPSS ver 13.0 was used for data analysis, and the χ2 method was used for comparisons within groups. RESULTS: The frequency of anti-SSA, anti-SSB, anti-GAD, anti-Sm, anti-ds DNA, AMA-LKM, ASMA, ANA and ICA were not significantly different between the groups. Levels of anti-TPO and anti-TG antibodies were found to be significantly higher (<0.001) in autoimmune hypothyroid patients when compared with other groups. CONCLUSION: In previous studies, an increased frequency of autoimmune diseases of other systems has been reported in patients with celiac disease. We found that the frequency of autoimmune antibodies specific for other autoimmune diseases was not higher in celiac disease.


Subject(s)
Adult , Female , Humans , Male , Autoantibodies/blood , Celiac Disease/immunology , Autoantibodies/classification , Autoimmune Diseases/immunology , Case-Control Studies , Hypothyroidism/immunology , Retrospective Studies
17.
J Gastroenterol ; 43(9): 705-10, 2008.
Article in English | MEDLINE | ID: mdl-18807132

ABSTRACT

BACKGROUND: Helicobacter pylori infection leads to different clinical outcomes depending on both host and bacterial factors. In a recent study, we identified H. pylori cagE and babA2 genotypes as independent predictors of duodenal ulcer (DU) and gastric cancer (GC) in dyspepsia patients, but no previous studies have examined the role of host-related genetic factors in Turkey. This time our aim was to evaluate whether polymorphisms of the interleukin 1B (IL-1B) and the interleukin 1 receptor antagonist (IL-1RN) genes are important factors in the differential expression of gastroduodenal diseases in H. pylori-positive dyspepsia patients. METHODS: Ninety-three H. pylori-positive patients, 30 with nonulcer dyspepsia (NUD), 30 with DU, and 33 with GC, were investigated. The IL-1B-511 and IL-1B-31 biallelic polymorphisms, and the IL-1RN intron 2 variable number tandem repeat were genotyped by polymerase chain reaction and single-strand confirmation polymorphism analysis. RESULTS: The IL-1RN-1/1 genotype was significantly more prevalent among patients with NUD than among those with GC (chi(2) = 9.270; P = 0.002), and the IL-1RN-1/2 genotype was significantly more common in patients with GC (chi(2) = 6.01; P = 0.014). Multivariate regression analysis showed that cagE, babA2, and IL-1RN-1/2 genotypes were independent predictors of GC, but when patients with benign disorders were grouped together (NUD + DU) and compared with patients with GC, regression analysis disclosed that babA2 (P = 0.000) and IL-1B-31 gene polymorphisms (CC or CT) (P = 0.01) were the only independent markers of GC. CONCLUSIONS: When analyzed together with host genetic factors, the well established bacterial risk factor babA2 seems to be the most important predictor of malignant disorders, and the presence of the IL-1B-31TT genotype emerges as a protective factor against them.


Subject(s)
Dyspepsia/genetics , Helicobacter Infections/complications , Helicobacter pylori , Interleukin 1 Receptor Antagonist Protein/genetics , Interleukin-1beta/genetics , Polymorphism, Genetic , Adhesins, Bacterial/metabolism , Adult , Aged , Aged, 80 and over , Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , Duodenal Ulcer/etiology , Duodenal Ulcer/genetics , Dyspepsia/microbiology , Female , Genotype , Helicobacter pylori/metabolism , Humans , Male , Middle Aged , Stomach Neoplasms/etiology , Stomach Neoplasms/genetics
18.
World J Gastroenterol ; 12(42): 6869-73, 2006 Nov 14.
Article in English | MEDLINE | ID: mdl-17106939

ABSTRACT

AIM: To investigate the frequency of seropositivity against CagA, VacA proteins and to determine their independent effects on the development of duodenal ulcer (DU) in Turkish patients. METHODS: The study was designed as a prospective one from a tertiary referral hospital. Dyspeptic patients who were referred to our endoscopy unit for upper gastrointestinal endoscopy between June 2003 and March 2004 and diagnosed to have DU or nonulcer dyspepsia (NUD) were included. Biopsies from the antrum and body of the stomach were taken in order to assess the current H pylori status by histology, rapid urease test and culture. Fasting sera were obtained from all patients and H pylori status of all sera was determined by IgG antibodies using an enzyme-linked immunosorbent assay (ELISA) kit. All seropositive patients were further analysed using Western blot assays detecting IgG antibodies against CagA and VacA proteins. The c2 test was used for statistical comparison of the values and age-sex adjusted multiple regression analysis was used to determine the independent effects of CagA and VacA seropositivities on the development of DU. RESULTS: Sixty-three patients with DU and 62 patients with NUD were eligible for the final analysis. Seropositivity for anti-CagA was detected in 51 of 62 (82%), and in 55 of 63 (87%) patients with NUD and DU, respectively (P = no significance), and seropositivity for anti-VacA was found in 25 of 62 (40% ) and in 16 of 63 (25%) patients, with NUD and DU, respectively. CONCLUSION: These findings suggest that none of these virulence factors is associated with the development of DU in the studied Turkish patients with dyspepsia.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Bacterial Proteins/immunology , Duodenal Ulcer/immunology , Duodenal Ulcer/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Duodenal Ulcer/epidemiology , Duodenal Ulcer/ethnology , Dyspepsia/blood , Dyspepsia/epidemiology , Dyspepsia/immunology , Dyspepsia/microbiology , Female , Helicobacter Infections/epidemiology , Helicobacter Infections/ethnology , Helicobacter Infections/immunology , Helicobacter Infections/microbiology , Humans , Male , Middle Aged , Prospective Studies , Regression Analysis , Seroepidemiologic Studies , Turkey/epidemiology , Turkey/ethnology , Virulence
19.
Acta Gastroenterol Belg ; 69(2): 213-6, 2006.
Article in English | MEDLINE | ID: mdl-16929618

ABSTRACT

Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disorder which is characterised by the triad of oculocutaneous albinism, platelet dysfunction and accumulation of ceroidlike pigment in tissues. Complications of the syndrome, such as fatal pulmonary fibrosis, renal failure and cardiomyopathy have been described. Granulomatous colitis has been documented in several families with the HPS. The bowel disease of the HPS is a unique type of inflammatory bowel disease with clinical features suggestive of idiopathic ulcerative colitis (UC) and pathologic features suggestive of Crohn's disease. We report a patient with HPS which was complicated by granulomatous colitis with perineal and rectovaginal fistulas refractory to antibiotics and azathioprine but dramatically responded to repeated infusions of infliximab.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Crohn Disease/drug therapy , Crohn Disease/etiology , Gastrointestinal Agents/therapeutic use , Hermanski-Pudlak Syndrome/complications , Hermanski-Pudlak Syndrome/drug therapy , Adolescent , Colitis, Ulcerative/drug therapy , Colitis, Ulcerative/etiology , Crohn Disease/pathology , Female , Hermanski-Pudlak Syndrome/pathology , Humans , Infliximab , Perineum/abnormalities , Rectovaginal Fistula/drug therapy , Rectovaginal Fistula/etiology
SELECTION OF CITATIONS
SEARCH DETAIL